NCT04669587

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: UNKNOWN

Phase: PHASE1, PHASE2

Sponsor: EnhancedBio USA Inc.

Condition: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer, Metastatic Breast Cancer

Signal summary

Public flags

Status signal: Unknown Status Signal

Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

Context when available

No stop reason available in the current public record.